Bal Pharma Ltd - BAL PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE083D01012
₹ 98.30 (0.61%) icon22 Apr, 2024, 12:00:00 AM
Open
₹ 98.55
Prev. Close
₹ 97.70
Turnover(lac)
₹ 8.00
Day's High
₹ 99.75
Day's Low
₹ 98.00
52 Wk High
₹ 132.45
52 Wk Low
₹ 77.50
Book Value
₹ 63.40
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 155.36
P/E
25.25
EPS
3.91
Div. Yield
1.01

Bal Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/22/2024 12:00:00 AM

    ₹ 98.3 0.60 0.61
  • Open
  • ₹ 98.55
  • Prev. Close
  • ₹ 97.7
  • Turnover(Lac.)
  • ₹ 8
  • Day's High
  • ₹ 99.75
  • Day's Low
  • ₹ 98
  • 52 Week's High
  • ₹ 132.45
  • 52 Week's Low
  • ₹ 77.5
  • Book Value
  • ₹ 63.4
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 155.36
  • P/E
  • 25.25
  • EPS
  • 3.91
  • Divi. Yield
  • 1.01

Bal Pharma Ltd Corporate Actions

25 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2024

12:00 AM

20 Nov , 2023

12:00 AM

20 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Oct , 2023

12:00 AM

31 Aug , 2023

12:00 AM

14 Aug , 2023

12:00 AM

AGM

Announcement date: 14 Aug , 2023

View Details

29 May , 2023

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 29 May , 2023

View Details

01 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Aug , 2023

12:00 AM

16 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Bal Pharma Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Bal Pharma Ltd SHAREHOLDING SNAPSHOT
23 April , 2024 | 06:13 AM

PROMOTER - TOTAL51.23%

Indian: 47.09%

Foreign: 4.1456%

NON-PROMOTER - TOTAL 48.77%

Institutions: 0.13%

Non-Institutions: 48.64%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Bal Pharma Ltd FINANCIALS

Bal Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Bal Pharma Ltd

  • Shailesh Siroya
  • Managing Director
  • C V Srinivas
  • Independent Director
  • Himesh Virupakshaya
  • Executive Director
  • H S Venkatesh
  • Independent Director
  • Nicola Neeladri
  • Independent Director
  • Jatish Sheth
  • Independent Director
  • Kotian Chittananda Damodar
  • Whole-time Director
  • Abdul Basith
  • Company Sec. & Compli. Officer

Summary

Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May 87. In Mar.90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations.BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The companys product range has been expanded with the introduction of AZIWIN, CAFIMOL & CORTIDERM.The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium - M, Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named SERVETUS has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market... Read More


Reports by Bal Pharma Ltd


Reports by Bal Pharma Ltd

Company FAQ

No Record Found